カリフォルニア州サンタクララ - 時価総額約6,000万ドルの医療技術企業HeartBeam, Inc. (NASDAQ: BEAT)は、1株1.70ドルでの公募価格を発表しました。同社は5,882,353株の普通株式を提供し、市場状況などにより2025年2月14日頃に募集を終了する予定です。InvestingProの ...
SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of ...
カリフォルニア州サンタクララ - 現在1株$2.12で取引されている時価総額5,650万ドルの医療技術のパイオニアHeartBeam, Inc. (NASDAQ: BEAT)は、革新的な12誘導心電図(ECG)合成ソフトウェアの510(k)申請を米国食品医薬品局(FDA)に提出したと発表しました。この ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at $1.70 per share, expecting to raise $10 million ...
Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/106.BfLtBoPo.js ...
HeartBeam, Inc, a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease ...
Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology. As the U.S. stock market experiences a downturn ...
SANTA CLARA, Calif., February 13, 2025--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock As the U.S. stock market navigates a mixed landscape of earnings ...